[1]
“Comparing the effectiveness of brolucizumab therapy alone versus that combined with subthreshold micropulse laser exposure in the treatment of diabetic macular edema”, Ukr. j. ophthalmol. , no. 2, pp. 16–20, Apr. 2023, doi: 10.31288/oftalmolzh202321620.